Lombard Medical Technologies plc
Description
Lombard Medical Technologies is a medical devices company developing stent grafts and other medical products for use in the treatment of vascular disease.
The Company's lead product, AorfixTM, is a stent graft for the treatment of aortic aneurysms, a balloon-like enlargement of the aorta which, if untreated, may rupture and cause death.
Stock Ticker
LMT
Chairman
Simon Neathercoat
CEO
Brian Howlett
FD
Tim Hall
Latest Headlines for Lombard Medical Technologies plc
Lombard Medical raises new cash for Aorfix development Friday, January 09, 2009
Lombard Medical Technologies conserving cashWednesday, December 10, 2008
Lombard Medical upbeat on positive international reaction to AorfixWednesday, November 26, 2008
Lombard Medical raises new cash to trade into next yearFriday, September 26, 2008
Lombard eyes Aorfix progress as group sales break £1m barrierThursday, March 20, 2008
Lombard Medical raises new cash to support 2008 operationsThursday, December 20, 2007
Lombard to work with Smith & NephewThursday, July 05, 2007
Lombard Medical wraps up Culzean dealWednesday, June 20, 2007
Lombard Medical’s Aorfix used in BrazilTuesday, May 22, 2007
Lombard Medical regenerative stent consortium awarded research fundingMonday, October 02, 2006
Lombard Medical Technologies to retain distribution rights for Aorfix AAAFriday, August 25, 2006
Lombard Medical announces positive clinical results on Aorfix stent graftWednesday, April 12, 2006
Commercialisation of Aorfix moves a step closer for Lombard MedicalFriday, February 17, 2006
|
Share Data
(15 minutes delayed)
| Latest trade time | 16:26:19 | | Share Price | 1.25 | | Change Today | 0.75 | | % Change Today | 150.00 | | Volume | 3304933 | | Today High | 1.35 | | Today Low | 0.50 | | 52 Week High | 15.50 | | 52 Week Low | 0.48 | No. of shares
in issue | 138m | | Market Capitalisation | £1.73m |
This is a solution provided by Digital Look Corporate
Solutions
incorporating their prices and data, on this site.
Terms & Conditions
|
|